查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999034

骨質密度檢測設備市場：中心型雙能量X光吸收法（DXA）、定量超音波、周邊型DXA，依最終用戶分類－2026-2032年全球市場預測

Bone Densitometer Market by Central DXA, Quantitative Ultrasound, Peripheral DXA, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，骨質密度檢測設備市場價值將達到 3.5514 億美元，到 2026 年將成長至 3.7687 億美元，到 2032 年將達到 5.0716 億美元，複合年成長率為 5.22%。

主要市場統計數據
基準年 2025 3.5514億美元
預計年份：2026年 3.7687億美元
預測年份 2032 5.0716億美元
複合年成長率 (%) 5.22%

隨著臨床需求、影像技術創新和醫療保健服務重點的交匯，骨骼密度測量技術的角色和採購方式正在被重新定義。

骨骼密度測量處於人口結構變化、臨床需求和影像技術創新三者交匯的階段，迫使臨床醫生、管理者和醫療設備製造商重新評估其工作重點。隨著人口老化和人們對骨骼健康意識的提高，曾經作為輔助手段的診斷過程如今在預防醫學和慢性病管理中發揮著核心作用。同時，技術進步正在改變集中式影像設施和分散式篩檢方法之間的平衡，為骨骼健康評估的地點、方式和評估人員創造了新的選擇。

技術小型化、先進分析和護理模式的整合正在改變臨床路徑、籌資策略和供應商差異化。

在骨骼密度測量領域，硬體、分析技術和診療模式的創新正在帶來革命性的變革，這些變革共同重塑臨床實踐和市場獎勵。更小巧、更便攜的設備正在拓展診斷應用範圍，使其不再局限於三級醫療機構，從而能夠在門診中心和社區診所進行即時篩檢（POC）。影像處理和人工智慧（AI）技術的同步發展，為自動化品管和高級骨折風險評估提供了支持，從而提高了診斷的可靠性並降低了檢查者之間的差異。

貿易政策的變化和關稅壓力正在促使醫療影像設備整個價值鏈進行供應鏈重組、進口總成本重新評估和籌資策略調整。

近期關稅調整和貿易政策變化給依賴跨境供應鏈供應醫療影像設備及其組件的供應商、經銷商和醫療服務提供者帶來了新的挑戰。關稅措施正在影響供應商的零件採購決策，許多製造商正在重新評估其全球製造地，以降低額外的進口成本並減少政策變化的風險。為此，一些製造商正在將零件採購轉移到其他地區，或加快本地組裝，以避免額外關稅並縮短前置作業時間。

診斷中心和醫院中特定模式部署對臨床工作流程、採購政策和設備設計要求的影響。

細分市場分析揭示了不同模式和醫療機構之間的交集，從而影響臨床效用、購買理由和採用模式。基於中心式雙能量X光吸收法（DXA），市場結構以診斷中心和醫院為中心。診斷中心通常採用此系統來支援骨折風險評估和骨質疏鬆症評估服務，優先考慮處理能力和門診追蹤；而醫院則利用中心式DXA開展綜合骨折聯絡項目，強調全面的護理協調，並用於住院和門診骨質疏鬆症管理。基於定量超音波（QUS），該技術常被診斷中心採用，用於在社區篩檢活動中優先考慮快速骨折風險篩檢和骨質疏鬆症評估；也被醫院採用，在放射科資源有限的情況下，用於分流、手術全期評估和床邊評估，作為中心式DXA的補充。這種基於外周 DXA 的模式通常部署在診斷中心，為社區推廣和與基層醫療合作提供移動、低成本的骨折風險和骨質疏鬆症評估方案；或者部署在醫院，因為醫院無法獲得中央 DXA，外周設備可以支持重點評估、目標患者群體的監測和術前評估。

區域監管差異、人口趨勢和醫療保健服務模式正在全球市場中形成不同的需求模式和區域性商業化策略。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的臨床重點、監管預期和商業策略的影響各不相同。在美洲，人口老化和廣泛的基層醫療網路推動了對便利診斷途徑和綜合骨折預防計畫的需求，醫療系統正在投資集中式和分散式骨骼密度解決方案，以支持長期管理和結果追蹤。同時，歐洲、中東和非洲地區呈現高度異質性，各國在法律規範、報銷模式和醫療基礎設施方面存在顯著差異。因此，供應商越來越傾向於尋求特定區域的監管批准和靈活的商業模式，以適應公共採購週期和國家篩檢政策。

競爭優勢源自於檢驗的影像診斷效能​​、整合的分析能力、強大的服務模式以及以合作夥伴主導的打入市場策略。

競爭格局的核心在於儀器性能、軟體分析、服務交付和商業性柔軟性之間的相互作用。領先的供應商透過經過檢驗的測量精度、低劑量成像以及與電子健康記錄和臨床決策支援系統的互通性來脫穎而出，而專注於特定領域的廠商則強調便攜性、經濟性和針對性應用，例如外周篩檢和社區骨折風險管理。服務模式也影響競爭格局。在資本預算受限且醫療系統要求營運成本可預測的環境下，提供維護、遠距離診斷和分析即服務等打包服務的公司蓬勃發展。

供應商和服務提供者採取切實可行的步驟，以加強臨床整合、建立供應鏈韌性並擴展服務主導經營模式，從而實現永續成長。

產業領導者應優先考慮能夠提升臨床相關性、業務永續營運和商業性靈活性的措施。首先，投資於互通性和臨床整合，確保骨骼密度測量數據能夠無縫流入電子健康記錄和治療路徑。這將加速臨床應用，並支援符合指南的決策。其次，實現供應鏈多元化，探索本地組裝和雙重採購模式，以降低貿易中斷和關稅波動帶來的風險，從而提高交貨可靠性並控制成本。第三，拓展服務範圍，引入軟體主導的分析、遠端維護和訂閱定價模式，將資本投資轉化為預算有限的醫療系統中可控的營運成本。

我們採用高度透明的調查方法，結合專家訪談、監管趨勢分析和產品對比評估，得出可操作的、檢驗的見解。

本研究整合了一手和第二手資料，旨在深入了解技術採納、臨床應用和商業性趨勢。第一手資料包括對臨床負責人、採購專家和行業高管的結構化訪談，以及產品規格、監管文件和說明設備性能和臨床效用的同行評審文獻。第二手資料包括公開的臨床指南、醫療系統採購文件和製造商的技術白皮書，這些資料揭示了工作流程整合和服務模式。

透過整合臨床趨勢、技術要求和操作措施，並將它們結合起來，我們確定了一條實現更廣泛應用和高價值骨骼健康評估的途徑。

總之，在人口結構變化、技術創新和醫療服務體系變革的推動下，骨骼密度測量正從小眾診斷工具發展成為預防性肌肉骨骼保健的核心要素。檢測方法的特性與醫療環境的相互作用決定了設備的實施方式及其臨床價值的實現。同時，貿易政策和供應鏈的考量增加了營運的複雜性，要求製造商和醫療系統都進行積極主動的管理。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章骨質密度檢測設備市場（以中心DXA分類）

  • 診斷中心
    • 骨折風險評估
    • 骨質疏鬆症評估
  • 醫院
    • 骨折風險評估
    • 骨質疏鬆症評估

第9章骨質密度檢測設備市場—超音波

  • 診斷中心
    • 骨折風險評估
    • 骨質疏鬆症評估
  • 醫院
    • 骨折風險評估
    • 骨質疏鬆症評估

第10章 周邊雙能量X光吸收法骨質密度檢測設備市場

  • 診斷中心
    • 骨折風險評估
    • 骨質疏鬆症評估
  • 醫院
    • 骨折風險評估
    • 骨質疏鬆症評估

第11章骨質密度檢測設備市場：依最終用戶分類

  • 醫院
  • 診斷影像中心
  • 專科診所
  • 研究機構

第12章骨質密度檢測設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章骨質密度檢測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章骨質密度檢測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國骨質密度檢測設備市場

第16章 中國骨質密度檢測設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • CompuMed, Inc.
  • DMS Group, Inc.
  • GE HealthCare Technologies Inc.
  • Hitachi Aloka Medical, Ltd.
  • Hologic, Inc.
  • Medilink Co., Ltd.
  • Medonica Co., Ltd.
  • Mindways Software, Inc.
  • Norland Medical Systems, Inc.
  • OsteoSys Co., Ltd.
  • Scanflex Healthcare AB
  • Siemens Healthineers AG
  • Sunlight Medical Ltd.
Product Code: MRR-3D2FD205D8B8

The Bone Densitometer Market was valued at USD 355.14 million in 2025 and is projected to grow to USD 376.87 million in 2026, with a CAGR of 5.22%, reaching USD 507.16 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 355.14 million
Estimated Year [2026] USD 376.87 million
Forecast Year [2032] USD 507.16 million
CAGR (%) 5.22%

How converging clinical demand, imaging innovation, and care delivery priorities are redefining the role and procurement of bone densitometry technologies

Bone densitometry stands at the intersection of demographic pressure, clinical need, and imaging innovation, forcing clinicians, administrators, and device manufacturers to re-evaluate priorities. As populations age and awareness of bone health increases, diagnostic pathways that were once ancillary now occupy central roles in preventive care and chronic disease management. Concurrently, technological advances are altering the balance between centralized imaging suites and decentralized screening approaches, creating new choices around where, how, and by whom bone health is assessed.

Clinicians increasingly demand tools that integrate with electronic health records, provide reproducible longitudinal assessments, and support risk stratification that informs therapy decisions. Health systems, meanwhile, seek devices and service models that improve throughput, minimize radiation exposure, and offer favorable operating economics. Manufacturers respond with slimmer form factors, software-driven analytics, and enhanced workflow integration to address these converging pressures. Consequently, purchasing committees and clinical leaders must weigh diagnostic accuracy against operational flexibility and total cost of ownership.

Looking ahead, the convergence of imaging, data analytics, and point-of-care delivery will redefine the value proposition of bone densitometers. Strategic stakeholders who anticipate these shifts and prioritize interoperability, clinician usability, and patient-centered workflows will secure competitive advantage and drive more consistent, guideline-concordant care across settings.

Technological miniaturization, advanced analytics, and integrated care models converging to transform clinical pathways, procurement strategies, and vendor differentiation

The bone densitometry landscape is experiencing transformative shifts driven by innovation in hardware, analytics, and care models that together reshape clinical practice and market incentives. Device miniaturization and portability extend diagnostic reach beyond tertiary centers, enabling point-of-care screening in outpatient centers and community clinics. Parallel advances in image processing and artificial intelligence support automated quality control and enhanced fracture risk assessment, which improves diagnostic confidence and reduces inter-operator variability.

Moreover, shifting clinical pathways place a premium on longitudinal monitoring and interoperability with electronic health records and clinical decision support systems. As a result, software ecosystems that enable seamless data transfer and integrate bone health metrics into treatment algorithms gain strategic importance. Regulatory emphasis on safety and data integrity has tightened verification requirements, prompting vendors to accelerate validation efforts and manufacturers to provide robust post-market surveillance.

Financial and operational pressures also drive change. Health systems increasingly favor tools that reduce patient throughput times and administrative burden. Consequently, bundled service offerings, subscription-based models for software and analytics, and integrated service contracts become more prominent. Taken together, these shifts favor vendors and health providers that deliver end-to-end solutions that combine reliable hardware, validated analytics, and streamlined clinical workflows.

Trade policy shifts and tariff pressures prompting supply chain reconfiguration, landed cost reassessment, and procurement adaptation across imaging equipment value chains

Recent tariff adjustments and trade policy developments have created a new layer of complexity for suppliers, distributors, and health providers that rely on cross-border supply chains for imaging equipment and components. Tariff measures influence supplier decisions on where to source subassemblies, with many manufacturers reassessing global manufacturing footprints to mitigate added import costs and reduce exposure to policy volatility. In response, some producers have shifted component sourcing to alternative geographies or accelerated local assembly to avoid incremental duties and reduce lead-time risk.

Operationally, the cumulative impact of tariffs manifests through increased landed costs, lengthened procurement cycles, and the need for more sophisticated supply chain risk management. Procurement teams now place greater emphasis on total landed cost analysis, longer-term supplier contracts, and dual-sourcing strategies to preserve continuity of supply. Consequently, distributors and service providers reevaluate pricing structures and warranty terms to maintain margins while remaining competitive.

Clinicians and administrators experience these dynamics through delayed equipment deliveries and, in some cases, adjusted capital planning. In turn, health systems may prioritize existing fleet optimization, preventive maintenance, and extended service contracts over immediate replacement purchases. Importantly, regulatory compliance and customs documentation have gained prominence, requiring closer coordination among procurement, legal, and logistics teams. Looking forward, companies that proactively adapt their supply chain strategies, streamline customs procedures, and offer flexible commercial terms will minimize disruption and preserve access to essential diagnostic capabilities.

How modality-specific deployment across Diagnostic Centers and Hospitals shapes clinical workflows, procurement choices, and device design imperatives

Segmentation analysis reveals how modality and care setting intersect to shape clinical utility, purchasing rationale, and adoption patterns. Based on Central DXA, the landscape is organized around Diagnostic Centers and Hospitals, with Diagnostic Centers frequently deploying their systems to support Fracture Risk Assessment and Osteoporosis Assessment services that prioritize throughput and outpatient follow-up, while Hospitals leverage central DXA for inpatient and outpatient osteoporosis management as well as integrated fracture liaison programs that emphasize comprehensive care coordination. Based on Quantitative Ultrasound, the technology often finds a foothold in Diagnostic Centers that prioritize rapid screening for fracture risk and osteoporosis assessment within community screening initiatives, and in Hospitals where it complements central DXA for triage, perioperative evaluation, and bedside assessment when radiology access is constrained. Based on Peripheral DXA, the modality is typically deployed in Diagnostic Centers that seek mobile, lower-cost options for fracture risk and osteoporosis assessment during community outreach and primary care collaborations, and in Hospitals where peripheral devices support focused assessments, monitoring of targeted patient cohorts, and preoperative evaluations when central DXA access is limited.

These segmentation patterns carry meaningful implications for manufacturers and health system planners. Devices optimized for Diagnostic Centers must balance ease of use, compact footprints, and throughput-oriented software, while hospital-grade systems require integration capabilities, advanced reporting, and robust service-level agreements. Moreover, reimbursement policies and clinical pathways differ by setting, which affects procurement timelines and capital allocation. Therefore, aligning product design, sales strategy, and clinical training with the distinct operational realities of Diagnostic Centers and Hospitals will enhance adoption and clinical value realization.

Regional regulatory diversity, demographic trends, and care delivery models creating differentiated demand patterns and localized commercialization strategies across global markets

Regional dynamics influence clinical priorities, regulatory expectations, and commercial strategies in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, aging demographics and broad primary care networks have increased demand for accessible diagnostic pathways and integrated fracture prevention programs, prompting health systems to invest in both centralized and decentralized densitometry solutions that support longitudinal management and outcome tracking. Conversely, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, reimbursement models, and health infrastructure vary widely across countries; as a result, vendors often pursue region-specific regulatory clearances and flexible commercial models that accommodate public procurement cycles and national screening initiatives.

In the Asia-Pacific region, rapid urbanization, expanding private healthcare delivery, and a growing emphasis on preventive health services stimulate demand for portable technologies and cloud-enabled analytics that facilitate broad population screening and continuity of care across fragmented providers. Additionally, regional manufacturing capabilities and policy incentives in certain markets encourage local assembly and partnerships, which can reduce lead times and lower logistical barriers. Across regions, regulatory harmonization efforts, cross-border data governance, and varying reimbursement structures require tailored market-entry strategies. Consequently, companies that invest in regional regulatory expertise, adaptive commercial models, and localized support infrastructure will be better positioned to capture opportunities while managing operational risks.

Competitive advantage emerges from validated imaging performance, integrated analytics, robust service models, and partner-driven market access strategies

Competitive dynamics center on the interplay between device capability, software analytics, service provision, and commercial flexibility. Leading vendors differentiate through validated measurement precision, low-dose imaging, and interoperability with electronic health records and clinical decision support systems, while niche players emphasize portability, affordability, and targeted applications such as peripheral screening or community-based fracture risk initiatives. Service models also shape competition; companies offering bundled maintenance, remote diagnostics, and analytics-as-a-service demonstrate resilience in environments where capital budgets are constrained and health systems seek predictable operating expenditures.

Partnerships and channel strategies increasingly determine market access. Distributors that combine equipment sales with training programs, installation services, and local clinical education create stickiness with provider customers. Additionally, strategic alliances between device manufacturers and software developers accelerate the deployment of advanced risk assessment tools and population health management dashboards. From a product lifecycle perspective, vendors that maintain rigorous clinical validation, timely software updates, and clear post-market surveillance protocols preserve clinician trust and regulatory compliance. Ultimately, competitive advantage accrues to organizations that align technological innovation with reliable service delivery and adaptable commercial terms that meet the operational needs of diverse clinical settings.

Practical steps for vendors and providers to enhance clinical integration, build supply chain resilience, and expand service-driven commercial models for sustainable growth

Industry leaders should prioritize actions that strengthen clinical relevance, operational resilience, and commercial agility. First, invest in interoperability and clinical integration so that densitometry data flows seamlessly into electronic health records and treatment pathways; doing so increases clinical uptake and supports guideline-aligned decision-making. Second, diversify supply chains and consider regional assembly or dual sourcing to reduce exposure to trade disruptions and tariff volatility, thereby improving delivery predictability and cost control. Third, expand service offerings to include software-driven analytics, remote maintenance, and subscription pricing that convert capital expenditures into manageable operating expenses for health systems with constrained budgets.

Additionally, accelerate clinical validation studies that demonstrate device performance across diverse patient cohorts and imaging environments. Strengthen training and credentialing programs for operators to reduce variability and optimize diagnostic yield. Engage proactively with payers and policy makers to clarify reimbursement pathways and to highlight the value of early detection in reducing downstream fracture-related costs. Finally, pursue partnerships with healthcare systems, academic centers, and technology firms to co-develop population health tools and decision support modules that embed bone densitometry into broader chronic disease management strategies. Taken together, these steps will enhance adoption, mitigate risk, and create sustainable differentiation.

Transparent methodological approach combining expert interviews, regulatory review, and comparative product assessment to derive actionable and validated insights

This research synthesized primary and secondary evidence to produce actionable insights into technology deployment, clinical adoption, and commercial dynamics. Primary inputs included structured interviews with clinical leaders, procurement specialists, and industry executives, supplemented by product specifications, regulatory filings, and peer-reviewed literature that describe device performance and clinical utility. Secondary inputs comprised publicly available clinical guidelines, health system procurement documents, and manufacturer technical whitepapers that illuminate workflow integration and service models.

Analytical methods combined qualitative thematic analysis with comparative product assessment to identify performance differentiators, as well as scenario-based supply chain mapping to evaluate tariff and policy impacts on procurement timelines. Validation steps included expert review panels and cross-checking with regulatory documentation to ensure technical accuracy. Throughout, emphasis rested on transparency of assumptions and reproducibility of analyses. Limitations included variability in national reimbursement practices and heterogeneity in clinical pathways across institutions, which the study addressed by presenting adaptable strategic implications rather than prescriptive operational directives.

Synthesis of clinical trends, technology imperatives, and operational actions that together define the path to broader adoption and higher-value bone health diagnostics

In conclusion, bone densitometry is evolving from a niche diagnostic into a central component of preventive musculoskeletal care, driven by demographic change, technological innovation, and shifts in care delivery. The interplay between modality characteristics and care settings dictates how devices will be adopted and where clinical value will be realized. Concurrently, trade policy and supply chain considerations add operational complexity that requires proactive management by manufacturers and health systems alike.

Stakeholders who focus on interoperability, clinical validation, and flexible commercial arrangements will secure the greatest advantage. Moreover, regional nuances necessitate localized strategies for regulatory approval, distribution, and service support. By prioritizing robust analytics, operator training, and resilient sourcing, organizations can reduce risk and accelerate the translation of diagnostic capability into improved patient outcomes. Ultimately, the organizations that translate these insights into coordinated clinical, operational, and commercial actions will lead the transition to more accessible and effective bone health management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Densitometer Market, by Central DXA

  • 8.1. Diagnostic Centers
    • 8.1.1. Fracture Risk Assessment
    • 8.1.2. Osteoporosis Assessment
  • 8.2. Hospitals
    • 8.2.1. Fracture Risk Assessment
    • 8.2.2. Osteoporosis Assessment

9. Bone Densitometer Market, by Quantitative Ultrasound

  • 9.1. Diagnostic Centers
    • 9.1.1. Fracture Risk Assessment
    • 9.1.2. Osteoporosis Assessment
  • 9.2. Hospitals
    • 9.2.1. Fracture Risk Assessment
    • 9.2.2. Osteoporosis Assessment

10. Bone Densitometer Market, by Peripheral DXA

  • 10.1. Diagnostic Centers
    • 10.1.1. Fracture Risk Assessment
    • 10.1.2. Osteoporosis Assessment
  • 10.2. Hospitals
    • 10.2.1. Fracture Risk Assessment
    • 10.2.2. Osteoporosis Assessment

11. Bone Densitometer Market, by End User

  • 11.1. Hospitals
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Specialty Clinics
  • 11.4. Research Institutions

12. Bone Densitometer Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bone Densitometer Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bone Densitometer Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bone Densitometer Market

16. China Bone Densitometer Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. CompuMed, Inc.
  • 17.6. DMS Group, Inc.
  • 17.7. GE HealthCare Technologies Inc.
  • 17.8. Hitachi Aloka Medical, Ltd.
  • 17.9. Hologic, Inc.
  • 17.10. Medilink Co., Ltd.
  • 17.11. Medonica Co., Ltd.
  • 17.12. Mindways Software, Inc.
  • 17.13. Norland Medical Systems, Inc.
  • 17.14. OsteoSys Co., Ltd.
  • 17.15. Scanflex Healthcare AB
  • 17.16. Siemens Healthineers AG
  • 17.17. Sunlight Medical Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE DENSITOMETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BONE DENSITOMETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BONE DENSITOMETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE DENSITOMETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BONE DENSITOMETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BONE DENSITOMETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BONE DENSITOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE DENSITOMETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 228. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)